Ultragenyx Pharmaceutical Lands $45,000,000 Series A Round
Feed Type
Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=98aaee1a-8317-4e65-8cd2-556242497227&Preview=1
Date 6/20/2011
Company Name Ultragenyx Pharmaceutical
Mailing Address 77 Digital Drive Novato, CA 94949
Company Description Ultragenyx is a new startup focused on developing therapeutics for rare diseases. The company is lead by Emil Kakkis, M.D., Ph.D., former CMO of BioMarin Pharmaceutical, and will build on management’s experience in choosing and developing products with clear mechanisms of action in untreated rare diseases.
Proceeds Purposes This funding will advance multiple rare disease product programs in the pipeline, as well as the development of new product candidates and partnerships.